Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma

International Journal of Molecular Medicine

Volumn 32, Issue 1, 2013, Pages 130-136

  Tang, Yi ^a   Wang, Ya Lan ^a   Yang, Lian ^a   Xu, Jian Xia ^a   Xiong, Wei ^a   Xiao, Ming ^a   Li, Ming ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Arginine ADP ribosyltransferase; Colon carcinoma; Nuclear factor B; Poly(ADP ribose) polymerase

Indexed keywords

(3 IODOBENZYL)GUANIDINE; 5 AMINOISOQUINOLINE; ADENOSINE TRIPHOSPHATE PHOSPHORIBOSYLTRANSFERASE; I KAPPA B; ISOQUINOLINE DERIVATIVE; LENTIVIRUS VECTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3-IODOBENZYLGUANIDINE; ADP RIBOSE TRANSFERASES; CELL LINE, TUMOR; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GPI-LINKED PROTEINS; HUMANS; INTESTINAL MUCOSA; ISOQUINOLINES; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES; RNA, SMALL INTERFERING;

EID: 84878230384     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1370     Document Type: Article

References (38)

1. Hassa PO, Haenni SS, Elser M and Hottiger MO: Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70: 789-829, 2006. (Pubitemid 44484693)
2. Moss J, Balducci E, Cavanaugh E, et al: Characterization of NAD: arginine ADP-ribosyltransferases. Mol Cell Biochem 193: 109-113, 1999. (Pubitemid 29176589)
3. Zolkiewska A, Nightingale MS and Moss J: Molecular characterization of NAD: arginine ADP-ribosyltransferase from rabbit skeletal muscle. Proc Natl Acad Sci USA 89: 11352-11356, 1992.
4. Corda D and Di Girolamo M: Functional aspects of protein mono-ADP-ribosylation. EMBO J 22: 1953-1958, 2003. (Pubitemid 36565521)
5. Corda D and Di Girolamo M: Mono-ADP-ribosylation: a tool for modulating immune response and cell signaling. Sci STKE 2002: pe53, 2002.
6. Helleday T, Bryant HE and Schultz N: Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy. Cell Cycle 4: 1176-1178, 2005. (Pubitemid 41365386)
7. Hao LX, Wang YL and LI YY: Correlation of PARP expression with P-selectin and ICAM-1 expression in colorectal carcinoma. Basic Clin Med 26: 882-887, 2006.
8. Li M, Cai L and Wang Y: Effect of poly(ADP-ribose) polymerase inhibition on liver metastasis of mouse colorectal carcinoma CR26 cell line in vivo. Acta Acad Med Mil Tert 30: 237-240, 2008.
9. Wang YL and Hao LX: Effect of 5-aminoisoquinolinone on the adhesion of colon carcinoma. Chin J Cancer Res 19: 119-123, 2007.
10. Qin Y Wang YL and Li YY: Effect of poly(ADP-ribose)polymerase inhibition on liver metastasis of mouse colorectal carcinoma CT26 cell line in vivo. Acta Acad Med Mil Tert 29: 1621-1624, 2008.
11. Wang J, Nemoto E, Kots AY, Kaslow HR and Dennert G: Regulation of cytotoxic T cells by ecto-nicotinamide adenine dinucleotide (NAD) correlates with cell surface GPI-anchored/arginine ADP-ribosyltransferase. J Immunol 153: 4048-4058, 1994.
12. Wang J, Nemoto E and Dennert G: Regulation of CTL by ecto-nictinamide adenine dinucleotide (NAD) involves ADP-ribosylation of a p56lck-associated protein. J Immunol 156: 2819-2827, 1996.
13. Okamoto S, Azhipa O, Yu Y, Russo E and Dennert G: Expression of ADP-ribosyltransferase on normal T lymphocytes and effects of nicotinamide adenine dinucleotide on their function. J Immunol 160: 4190-4198, 1998. (Pubitemid 28217272)
14. Adriouch S, Ohlrogge W, Haag F, Koch-Nolte F and Seman M: Rapid induction of naive T cell apoptosis by ecto-nicotinamide adenine dinucleotide: requirement for mono(ADP-ribosyl) transferase 2 and a downstream effector. J Immunol 167: 196-203, 2001. (Pubitemid 32567778)
15. Akai T, Nabeya Y, Yahiro K, et al: Helicobacter pylori induces mono-(adenosine 5′-diphosphate)-ribosylation in human gastric adenocarcinoma. Int J Oncol 29: 965-972, 2006.
16. Yang L, Wang Y, Sheng Y, Xiong W, Xu J, Tang Y and Li X: The correlation of ART1 expression with angiogenesis in colorectal carcinoma and it relationship with VEGF and integrin αVβ3 expressions. Basic Clin Med 9: 1064-1069, 2012.
17. Thyberg J, Hultgårdh-Nilsson A and Kallin B: Inhibitors of ADP-ribosylation suppress phenotypic modulation and proliferation of smooth muscle cells cultured from rat aorta. Differentiation 59: 243-252, 1995. (Pubitemid 26004222)
18. Brac T and Ebisuzaki K: PolyADP ribosylation and Friend erythroleukemic-cell differentiation: action of poly(ADP-ribose) polymerase inhibitors. Differentiation 34: 139-143, 1987.
19. Colon-Otero G, Sando JJ, Sims JL, McGrath E, Jensen DE and Quesenberry PJ: Inhibition of hemopoietic growth factor-induced proliferation by adenosine diphosphate-ribosylation inhibitors. Blood 70: 686-693, 1987. (Pubitemid 18027399)
20. Francis G, Gray D, Berney J, Wing M, Guimaraes J and Hoffbrand A: Role of ADP-ribosyltransferase in differentiation of human granulocyte-macrophage progenitors to the macro phage lineage. Blood 62: 1055-1062, 1983. (Pubitemid 14237329)
21. Kuo ML, Chau YP, Wang JH and Shiah SG: Inhibitors of poly(ADP-ribose) polymerase block nitric oxide-induced apoptosis but not differentiation in human leukemia HL-60 cells. Biochem Biophys Res Commun 219: 502-508, 1996.
22. Terada M, Fujiki H, Marks PA and Sugimura T: Induction of erythroid differentiation of murine erythroleukemia cells by nicotinamide and related compounds. Proc Natl Acad Sci USA 76: 6411-6414, 1979. (Pubitemid 10163408)
23. Luo J, Kamata H and Karin M: IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest 115: 2625-2632, 2005. (Pubitemid 41434385)
24. Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitina tion: the control of NF- κB activity. Annu Rev Immunol 18: 621-663, 2000. (Pubitemid 30365393)
25. Virág L and Szabó C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54: 375-429, 2002.
26. Pan J, Fauzee NJ, Wang YL, et al: Effect of silencing PARG in human colon carcinoma LoVo cells on the ability of HUVEC migration and proliferation. Cancer Gene Ther 19: 715-722, 2012.
27. Loesberg C, van Rooij H, and Smets LA: Meta-iodobenzylguanidine (MIBG), a novel high -affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation). Biochim Biophys Acta 1037: 92-99, 1990. (Pubitemid 20033639)
28. Mota-Filipe H, Sepodes B, McDonald M, Cuzzocrea S, Pinto R and Thiemermann C: The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat. Med Sci Monit 8: BR444-BR453, 2002. (Pubitemid 35429210)
29. Fromowitz FB, Viola MV, Chao S, et al: Ras p21 expression in the progression of breast cancer. Hum Pathol 18: 1268-1275, 1987. (Pubitemid 18018958)
30. Qin JM, Fu XY, Li SJ, et al: Gene and protein expressions of p28GANK in rat with liver regeneration. World J Gastroenterol 9: 2523-2527, 2003.
31. Kato J, Zhu J, Liu C, et al: ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis. Cancer Res 71: 5327-5335, 2011.
32. Moss J, Stanley S, Nightingale M, et al: Molecular and immu nological characterization of ADP-ribosylarginine hydrolases. J Biol Chem 267: 10481-10488, 1992.
33. Yau L, Litchie B, Thomas S, Storie B, Yurkova N and Zahradka P: Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression. Eur J Biochem 270: 101-110, 2003. (Pubitemid 36061254)
34. Bourne HR, Sanders DA and McCormick F: The GTPase superfamily: conserved structure and molecular mechanism. Nature 349: 117-127, 1991. (Pubitemid 21912023)
35. Hwang YS, Hodge JC, Sivapurapu N and Lindholm PF: Lysophosphatidic acid stimulates PC-3 prostate cancer cell matrigel invasion through activation of RhoA and NF-κB activity. Mol Carcinog 45: 518-529, 2006.
36. Cho SG, Li D, Stafford LJ, et al: KiSS1 suppresses TNFα-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-κB activation. J Cell Biochem 107: 1139-1149, 2009.
37. Su X, Tang Z, Li Q, et al: Expression and significance of RhoA and NF-κB in human gastric carcinoma. Zhonghua Zhong Liu Za Zhi 33: 276-279, 2011 (In Chinese).
38. Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R and Lacal JC: Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev 11: 463-475, 1997. (Pubitemid 27097645)